Ken Griffin's position in Viridian Therapeutics is currently worth $9.1 Million. That's 0.01% of their equity portfolio (1214th largest holding). The investor owns 1.17% of the outstanding Viridian Therapeutics stock. The first Viridian Therapeutics trade was made in Q1 2021. Since then Ken Griffin bought shares five more times and sold shares on six occasions. The investor's estimated purchase price is $13.3 Million, resulting in a loss of 32%.